Evidence map›Paper›PMID 37049786›Full record

ArticleMolecules (Basel, Switzerland)2023

Development of FRET and Stress Granule Dual-Based System to Screen for Viral 3C Protease Inhibitors.

Jingjing Zhang, Yingpei Jiang, Chunxiu Wu, Dan Zhou, Jufang Gong, Tiejun Zhao, Zhigang Jin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jingjing ZhangCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Yingpei JiangCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Chunxiu WuCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Dan ZhouCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Jufang GongCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Tiejun ZhaoCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.
Zhigang JinCollege of Life Sciences, Zhejiang Normal University, Jinhua 321004, China.ORCID 0000-0001-7557-2968
Zhejiang Normal University · CN

Funding

Key Project of Zhejiang Province Jinhua City Science and Technology Bureau 2021-3-146, 2020XG-09National Natural Science Foundation of China 31970755Zhejiang Provincial Natural Science Foundation of China LY21C120001
6 · The paper itself

Abstract

3C proteases (3Cpros) of picornaviruses and 3C-like proteases (3CLpros) of coronaviruses and caliciviruses represent a group of structurally and functionally related viral proteases that play pleiotropic roles in supporting the viral life cycle and subverting host antiviral responses. The design and screening for 3C/3CLpro inhibitors may contribute to the development broad-spectrum antiviral therapeutics against viral diseases related to these three families. However, current screening strategies cannot simultaneously assess a compound's cytotoxicity and its impact on enzymatic activity and protease-mediated physiological processes. The viral induction of stress granules (SGs) in host cells acts as an important antiviral stress response by blocking viral translation and stimulating the host immune response. Most of these viruses have evolved 3C/3CLpro-mediated cleavage of SG core protein G3BP1 to counteract SG formation and disrupt the host defense. Yet, there are no SG-based strategies screening for 3C/3CLpro inhibitors. Here, we developed a fluorescence resonance energy transfer (FRET) and SG dual-based system to screen for 3C/3CLpro inhibitors in living cells. We took advantage of FRET to evaluate the protease activity of poliovirus (PV) 3Cpro and live-monitor cellular SG dynamics to cross-verify its effect on the host antiviral response. Our drug screen uncovered a novel role of Telaprevir and Trifluridine as inhibitors of PV 3Cpro. Moreover, Telaprevir and Trifluridine also modulated 3Cpro-mediated physiological processes, including the cleavage of host proteins, inhibition of the innate immune response, and consequent facilitation of viral replication. Taken together, the FRET and SG dual-based system exhibits a promising potential in the screening for inhibitors of viral proteases that cleave G3BP1.

Indexed as

Fluorescence Resonance Energy TransferViral Protease InhibitorsAntiviral AgentsDNA HelicasesHumansPoly-ADP-Ribose Binding ProteinsProtease InhibitorsRNA HelicasesRNA Recognition Motif ProteinsStress GranulesTrifluridineViral ProteinsAntiviral AgentsDNA HelicasesG3BP1 protein, humanPoly-ADP-Ribose Binding ProteinsProtease InhibitorsRNA HelicasesRNA Recognition Motif ProteinsTrifluridineViral Protease InhibitorsViral Proteins3C proteasefluorescence resonance energy transferG3BP1protease inhibitorstress granulesTelaprevirTrifluridine

Identifiers

PMID37049786
PMCPMC10096049
OpenAlexW4361295992

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.